Table 5.
Comparison of Continuous Outcomes Between Higher and Lower Adherence Classes at 24 Months
| Outcome | Higher Unadjusted Mean (SD) (N = 142) |
Lower Unadjusted Mean (SD) (N = 44) |
Unadjusted Difference (95% CI) P Value |
Higher Adjusted Mean (SE) |
Lower Adjusted Mean (SE) |
Adjusted Difference (95% CI) P Value |
|---|---|---|---|---|---|---|
| Urinary Distress Inventory | 39.3 (48.4) | 51.2 (63.1) | −11.9 (−35.5 to 11.6) .31 |
30.2 (9.5) | 41.5 (11.5) | −11.3 (−31.7 to 9.1) .27 |
| Pelvic Organ Prolapse Distress Inventory | 44.1 (55.9) | 61.3 (75.9) | −17.2 (−45.4 to 11) .22 |
36.5 (10.6) | 48.4 (12.7) | −11.9 (−34.6 to 10.7) .30 |
| Colorectal-Anal Distress Inventory | 49.7 (58.1) | 63.9 (79.2) | −14.2 (−43.6 to 15.2) .34 |
41.9 (11) | 54.8 (13.3) | −12.9 (−36.4 to 10.7) .28 |
| Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire | 36.7 (6.1) | 32.8 (10.1) | 3.8 (−1.1 to 8.8) .12 |
36.6 (0.9) | 32.8 (1.6) | 3.8 (0.1 to 7.6) .04 |
| Incontinence Severity Index | 2.7 (3.4) | 2.7 (2.9) | 0 (−1.3 to 1.2) .98 |
2 (0.6) | 1.9 (0.7) | 0.1 (−1.2 to 1.4) .93 |
| Pelvic Muscle Strength (Brink Score) | 8.2 (2.1) | 8 (2.0) | 0.2 (−0.6 to 1.0) .57 |
8 (0.3) | 8.1 (0.4) | −0.1 (−0.9 to 0.6) .70 |